Roche Holding | ROG - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 6.57B 2.82B 2026-06
Alcon AG USD 1.58B 80M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
Amgen USD 13.99B 1.95B 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Bayer EUR 5.73B 943M 2026-03
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
Fresenius EUR 2.06B 752M 2026-03
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Genmab DKK 1.72B 46M 2025-12
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Lonza CHF 719M 188M 2025-12
Merck EUR 2.33B 77M 2025-12
Merck USD 5.33B 9.24B 2026-03
Novartis USD 7.62B 739M 2026-06
Orion EUR 199.3M 38.4M 2026-03
Pfizer USD 976M 727M 2026-06
Philips EUR 1.79B 803M 2026-06
Recordati EUR 391.38M 10.92M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
UCB EUR 1.57B 1.14B 2024-12